Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115582) titled 'The Role and Molecular Mechanism of PERK-Mediated Kinase-Dependent Necroptosis in Chronic Obstructive Pulmonary Disease' on Dec. 29, 2025.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Jiaxing First Hospital
Condition:
Chronic Obstructive Pulmonary Disease
Intervention:
Healthy controls:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Healthy controls:30;COPD group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=303001
Published by HT Digital Content...